Xcout Intel
Nalu Bio, Inc.
Nalu Bio, Inc. is a San Francisco, California-based biotechnology company that produces chemistry-based cannabinoids designed to treat inflammatory, immune, and metabolic diseases.
Subscribe to see Nalu Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nalu Bio, Inc. at a glance
Nalu Bio, Inc. is a synthetically-derived cannabinoid company headquartered in United States. Its most recent funding round raised $4.8M in January 2023. Xcout tracks 10 named people at Nalu Bio, Inc., including Bill Kehoe (Chief Financial Officer).
Nalu Bio, Inc. leadership
- Bill KehoeChief Financial Officer
- Alex DorenbaumChief Medical Officer
- Glenn SammisChief Chemist
- Grazia PiizziChief Scientific Officer
- Caitlyn KrebsCo-founder + CEO
- Phyllis WhiteleyCo-founder
4 more named people on record for Nalu Bio, Inc., with roles, board committees and tenure — see the full roster →
Nalu Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.8M | — | |
| Series A | $12M | 9 named | |
| Seed | $2M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nalu Bio, Inc. competitors
A few of Nalu Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
BRC Therapeutics is a pharmaceutical company headquartered in Castroville, California. The company focuses on developing proprietary cannabinoid therapeutics and innovative treatments to provide relief from pain and neurological conditions.
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Founded in 2016 and headquartered in Toronto, Canada, Avicanna is a biopharmaceutical company that has strictly focused on the medical applications and potential of cannabinoids. The company conducts its research and development primarily out of Canada and has dedicated over nine years to cannabinoid research and product development.
Structure Therapeutics is a science-driven, clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule and peptide therapeutics to treat chronic metabolic and pulmonary diseases.
Get Nalu Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Nalu Bio, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nalu Bio, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access